147 related articles for article (PubMed ID: 21354998)
1. Neuromuscular pharmacodynamics of mivacurium in adults with major burns.
Han TH; Martyn JA
Br J Anaesth; 2011 May; 106(5):675-9. PubMed ID: 21354998
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of mivacurium chloride in 13- to 18-yr-old adolescents with thermal injury.
Martyn JA; Chang Y; Goudsouzian NG; Patel SS
Br J Anaesth; 2002 Oct; 89(4):580-5. PubMed ID: 12393359
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase.
Naguib M; Daoud W; el-Gammal M; Ammar A; Turkistani A; Selim M; Altamimi W; Sohaibani MO
Anesthesiology; 1995 Oct; 83(4):694-701. PubMed ID: 7574048
[TBL] [Abstract][Full Text] [Related]
4. Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury.
Martyn JA; Goudsouzian NG; Chang Y; Szyfelbein SK; Schwartz AE; Patel SS
Anesthesiology; 2000 Jan; 92(1):31-7. PubMed ID: 10638896
[TBL] [Abstract][Full Text] [Related]
5. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients.
Ostergaard D; Jensen FS; Jensen E; Skovgaard LT; Viby-Mogensen J
Acta Anaesthesiol Scand; 1992 Oct; 36(7):702-6. PubMed ID: 1441874
[TBL] [Abstract][Full Text] [Related]
6. Effect of metoclopramide on mivacurium-induced neuromuscular block.
Motamed C; Kirov K; Combes X; Dhonneur G; Duvaldestin P
Acta Anaesthesiol Scand; 2002 Feb; 46(2):214-6. PubMed ID: 11942874
[TBL] [Abstract][Full Text] [Related]
7. [Neuromuscular and cardiovascular effect of mivacurium in anesthesia induction in patients with renal failure].
Blobner M; Jelen-Esselborn S; Mann R; Kling M; Schneider G; Schneck HJ; Kochs E
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):15-21. PubMed ID: 8868527
[TBL] [Abstract][Full Text] [Related]
8. Influence of metoclopramide on plasma cholinesterase and duration of action of mivacurium.
Skinner HJ; Girling KJ; Whitehurst A; Nathanson MH
Br J Anaesth; 1999 Apr; 82(4):542-5. PubMed ID: 10472219
[TBL] [Abstract][Full Text] [Related]
9. [Neuromuscular recovery following mivacurium is predictable in patients with severe systemic disease prognoses].
Blobner M; Busley R; Mann R; Jelen-Esselborn S; Kochs E
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Oct; 34(10):638-41. PubMed ID: 10548961
[TBL] [Abstract][Full Text] [Related]
10. [Prolonged neuromuscular block after mivacurium injection].
Viggiano M; Soler C; Dumont JC; Pellissier D; François G
Ann Fr Anesth Reanim; 1995; 14(6):502-4. PubMed ID: 8745974
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of mivacurium in severely burned patients.
Werba AE; Neiger FX; Bayer GS; Schultz AM; Maitz PK; Wolrab C
Burns; 1996 Feb; 22(1):62-4. PubMed ID: 8719320
[TBL] [Abstract][Full Text] [Related]
12. Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block.
Naguib M; Samarkandi AH; Bakhamees HS; Turkistani A; Alharby SW
Br J Anaesth; 1996 Sep; 77(3):424-6. PubMed ID: 8949825
[TBL] [Abstract][Full Text] [Related]
13. [Value of the monitoring of curarisation during prolonged mivacurium induced neuromuscular block].
Avargues P; Cros AM; Dardel E; Darriet M; Biteau N
Ann Fr Anesth Reanim; 1995; 14(6):511-3. PubMed ID: 8745977
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacodynamics and clinical adverse effects of mivacurium. The effect of oral premedication with H1/H2 antagonists].
Mayer M; Doenicke A; Nebauer AE; Rosenberger C; Lorenz W; Peter K
Anaesthesist; 1993 Sep; 42(9):592-6. PubMed ID: 8105716
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhosis.
Devlin JC; Head-Rapson AG; Parker CJ; Hunter JM
Br J Anaesth; 1993 Aug; 71(2):227-31. PubMed ID: 8123397
[TBL] [Abstract][Full Text] [Related]
16. Onset and duration of mivacurium-induced neuromuscular block in patients with Duchenne muscular dystrophy.
Schmidt J; Muenster T; Wick S; Forst J; Schmitt HJ
Br J Anaesth; 2005 Dec; 95(6):769-72. PubMed ID: 16183677
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
[TBL] [Abstract][Full Text] [Related]
18. Effect of renal function on neuromuscular block induced by continuous infusion of mivacurium.
Blobner M; Jelen-Esselborn S; Schneider G; Mann R; Kling M; Luppa P; Schneck HJ; Kochs E
Br J Anaesth; 1995 Apr; 74(4):452-4. PubMed ID: 7734267
[TBL] [Abstract][Full Text] [Related]
19. [Prolonged neuromuscular block after administration of mivacurium caused by plasma psueudocholinesterase deficiency].
Kaiser E; Petit D; Quinot JF; Suppini A; Sallaberry M
Ann Fr Anesth Reanim; 1995; 14(6):505-7. PubMed ID: 8745975
[TBL] [Abstract][Full Text] [Related]
20. Prolonged mivacurium infusion in young and elderly adults.
Goudsouzian N; Chakravorti S; Denman W; Schwartz A; Yang HS; Cook DR
Can J Anaesth; 1997 Sep; 44(9):955-62. PubMed ID: 9305559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
